dapsone and Recrudescence studies

Research Excerpts

Excerpt	Relevance	Reference
"Dapsone is one of the important drugs in the treatment of leprosy."	9.22	Risk factors for dapsone resistance in leprosy patients: a systematic meta-analysis. ( Jiang, H; Shi, Y; Wang, C; Wang, H; Wang, Z; Wu, Z, 2022)
"The cure rates of two treatment regimens in PB leprosy were compared in a prospective randomized trial: treatment U consisting of a single dose of rifampicin 40 mg/K bodyweight, and treatment A of rifampicin 1500 mg in a single dose, followed by one year of daily dapsone 100 mg."	9.07	A controlled therapeutic trial in paucibacillary leprosy comparing a single dose of rifampicin with a single dose of rifampicin followed by one year of daily dapsone. The Collaborative Study Group for the Treatment of Leprosy in Zaire. ( Groenen, G; Janssens, L; Kuykens, L; Mputu, LB; Pattyn, SR, 1991)
"The objective of the present study was to define short-course treatment regimens for PB leprosy and to compare them with the 'classical' dapsone treatment and the WHO-PB regimen."	9.06	Evaluation of five treatment regimens, using either dapsone monotherapy or several doses of rifampicin in the treatment of paucibacillary leprosy. ( Baquillon, G; Husser, JA; Jamet, P; Maiga, M; Pattyn, SR, 1990)
"A clinical trial was initiated at ALERT, Addis Ababa, Ethiopia, to study the effect of one-year supplementary treatment on the incidence of dapsone-resistant leprosy in lepromatous patients already on dapsone monotherapy."	9.05	Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment. ( Mengistu, G; Warndorff van Diepen, T, 1985)
"Patients with borderline-lepromatous (BL) or fully lepromatous (LL) leprosy were treated in the sanitarium for approximately 1 year with oral rifampin (600 mg daily) or with oral dapsone (100 mg daily)."	9.04	Rifampin therapy of lepromatous leprosy. ( , 1975)
"Acedapsone (DADDS), a repository sulfone given by injection five times a year, has been used since 1967 for the treatment of all leprosy patients in the Karimui, an area of diffic-lt access."	9.04	Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years. ( McRae, DH; Russell, DA; Scott, GC; Shepard, CC; Vincin, DR, 1975)
" We report here an unusual case of relapse of toxoplasmic encephalitis in an HIV-infected patient, possibly due to a drug-to-drug interaction between dapsone and minocycline."	7.75	Drug-to-drug interaction between dapsone and minocycline: an unusual cause of relapse of toxoplasmic encephalitis in an HIV-infected patient. ( Bigé, N; Gallien, S; Gervais, A; Kitzis, MD; Leport, C; Longuet, P, 2009)
"794 MB leprosy patients who had been released from treatment after dapsone monotherapy were selected, amongst them 657 were re-treated for 1 year using the modified multidrug therapy regimen (mMDT) including rifampicin, clofazimine and dapsone, and 137 patients were observed as control cases."	7.75	Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy. ( Chen, J; Jing, Z; Zhang, R; Zhou, D, 2009)
"To detect the presence of rifampin- and dapsone-resistant strains of Mycobacterium leprae in three patients with recurring leprosy and clinically-suspected antimicrobial resistance through molecular techniques."	7.74	[Study of rifampin and dapsone resistance in three patients with recurring leprosy]. ( Beltrán, C; Cardona-Castro, N; Gómez, Y; Hernández, E; Kimura, M; Rodríguez, G; Villegas, S; Vissa, VD, 2008)
"Dapsone has been used successfully as adjuvant therapy for bullous pemphigoid (BP)."	7.73	Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases. ( Bröcker, EB; Goebeler, M; Kraensel, R; Rzany, B; Schmidt, E; Sinkgraven, R; Zillikens, D, 2005)
"Based upon the data from the Chinese National System for Leprosy Surveillance, this paper reports on the relapses in 297,343 leprosy patients [multibacillary (MB) 106,518, paucibacillary (PB) 190,825] cured by dapsone monotherapy."	7.70	Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy. ( Chen, XS; Jiang, C; Li, WZ; Ye, GY, 1999)
"We report the first case of eosinophilic pustular folliculitis (Ofuji's disease) which was successfully treated with acitretin."	7.69	[Ofuji's eosinophilic pustular folliculitis. Efficacy of acitretin]. ( Bergoend, H; Catteau, B; Delaporte, E; Dubost-Brama, A; Piette, F; Warembourg, A, 1997)
"Before implementation of multidrug therapy (MDT), leprosy patients who were clinically inactive, skin-smear negative and had been treated with dapsone monotherapy for at least 5 years (paucibacillary patients) or for at least 10 years (multibacillary patients) were released from treatment."	7.68	Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. ( Becx-Bleumink, M, 1992)
"In an open study, a total of 18 patients with proven bullous pemphigoid (16 new patients and two in relapse) were treated with a trial of dapsone (17 patients) or sulphonimide (one patient)."	7.67	Dapsone as first line therapy for bullous pemphigoid. ( Millard, PR; Venning, VA; Wojnarowska, F, 1989)
"This is a report on two cases with pemphigus vulgaris effectively controlled by dapsone."	7.66	Dapsone in the treatment of pemphigus vulgaris. ( Friedman-Birnbaum, R; Haim, S, 1978)
"The 1,659 non-leprous people in a Micronesian population experiencing an annual leprosy incidence rate of about 7/1,000 were offered 15 acedapsone (DADDS) injections during 1967--1970 for leprosy prevention purposes."	7.66	Acedapsone in the prevention of leprosy: field trial in three high prevalence villages in Micronesia. ( Fasal, P; Jano, B; Russell, DA; Shepard, CC; Worth, RM, 1979)
"This paper summarises our clinical experience with clofazimine in the treatment of 25 cases of reactive states of lepromatous and borderline leprosy and 7 lepromatous patients not responding to dapsone."	7.65	Clinical trial with clofazimine in leprosy. ( Dongre, VV; Ganapati, R, 1976)
" Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection."	6.50	Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014)
"We describe a 46-year-old man with Hodgkin's disease in whom neutrophilic eccrine hidradenitis developed after each of the first two treatments with lomustine."	6.39	Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis. ( Knowles, SR; Poldre, P; Shapiro, L; Shear, NH, 1996)
"Dapsone is a chemotherapeutic agent with anti-inflammatory properties that is used as a steroid-sparing agent in PV."	5.43	Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study. ( Barzilai, A; Baum, S; Debby, A; Gilboa, S; Trau, H, 2016)
"IgA pemphigus is a particular entity among autoimmune blistering intraepidermal diseases."	5.39	[Efficacy of acitretin in IgA pemphigus]. ( Bellissen, A; Gosset, P; Lasek, A; Lebas, D; Modiano, P; Wantz, M, 2013)
"Rapid recurrence after stopping treatment however suggests that anti-inflammatory effects may predominate."	5.37	Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. ( Boer, J; Ingvarsson, G; Jemec, GB; Szepietowski, JC; Yazdanyar, S, 2011)
"Dapsone is one of the important drugs in the treatment of leprosy."	5.22	Risk factors for dapsone resistance in leprosy patients: a systematic meta-analysis. ( Jiang, H; Shi, Y; Wang, C; Wang, H; Wang, Z; Wu, Z, 2022)
"The cure rates of two treatment regimens in PB leprosy were compared in a prospective randomized trial: treatment U consisting of a single dose of rifampicin 40 mg/K bodyweight, and treatment A of rifampicin 1500 mg in a single dose, followed by one year of daily dapsone 100 mg."	5.07	A controlled therapeutic trial in paucibacillary leprosy comparing a single dose of rifampicin with a single dose of rifampicin followed by one year of daily dapsone. The Collaborative Study Group for the Treatment of Leprosy in Zaire. ( Groenen, G; Janssens, L; Kuykens, L; Mputu, LB; Pattyn, SR, 1991)
"The objective of the present study was to define short-course treatment regimens for PB leprosy and to compare them with the 'classical' dapsone treatment and the WHO-PB regimen."	5.06	Evaluation of five treatment regimens, using either dapsone monotherapy or several doses of rifampicin in the treatment of paucibacillary leprosy. ( Baquillon, G; Husser, JA; Jamet, P; Maiga, M; Pattyn, SR, 1990)
"A clinical trial was initiated at ALERT, Addis Ababa, Ethiopia, to study the effect of one-year supplementary treatment on the incidence of dapsone-resistant leprosy in lepromatous patients already on dapsone monotherapy."	5.05	Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment. ( Mengistu, G; Warndorff van Diepen, T, 1985)
"Patients with borderline-lepromatous (BL) or fully lepromatous (LL) leprosy were treated in the sanitarium for approximately 1 year with oral rifampin (600 mg daily) or with oral dapsone (100 mg daily)."	5.04	Rifampin therapy of lepromatous leprosy. ( , 1975)
"Acedapsone (DADDS), a repository sulfone given by injection five times a year, has been used since 1967 for the treatment of all leprosy patients in the Karimui, an area of diffic-lt access."	5.04	Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years. ( McRae, DH; Russell, DA; Scott, GC; Shepard, CC; Vincin, DR, 1975)
"From 2009 to 2015, multi-bacillary leprosy cases at sentinel sites of 19 countries were studied for resistance to rifampicin, dapsone and ofloxacin by PCR sequencing of the drug-resistance-determining regions of the genes rpoB, folP1 and gyrA."	3.88	Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15. ( Cambau, E; Cardona-Castro, N; Cauchoix, B; Cole, ST; Cooreman, EAWD; Gillini, L; Gupta, UD; Hagge, D; Hongseng, W; Indropo, A; Johnson, RC; Kai, M; Lavania, M; Matsuoka, M; Miyamoto, Y; Pannikar, VK; Pemmaraju, VRR; Rosa, PS; Saunderson, P; Srikantam, A; Suffys, P; Vissa, V; Williams, D, 2018)
" Histological analysis of one of these nodules resulted in diagnosis of chronic erythema elevatum diutinum and treatment with dapsone was initiated."	3.76	[Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient]. ( Andre, C; Bagot, M; Duriez, P; Lascaux-Cametz, AS; Maksimovic, L; Ortonne, N; Revuz, J, 2010)
"794 MB leprosy patients who had been released from treatment after dapsone monotherapy were selected, amongst them 657 were re-treated for 1 year using the modified multidrug therapy regimen (mMDT) including rifampicin, clofazimine and dapsone, and 137 patients were observed as control cases."	3.75	Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy. ( Chen, J; Jing, Z; Zhang, R; Zhou, D, 2009)
" We report here an unusual case of relapse of toxoplasmic encephalitis in an HIV-infected patient, possibly due to a drug-to-drug interaction between dapsone and minocycline."	3.75	Drug-to-drug interaction between dapsone and minocycline: an unusual cause of relapse of toxoplasmic encephalitis in an HIV-infected patient. ( Bigé, N; Gallien, S; Gervais, A; Kitzis, MD; Leport, C; Longuet, P, 2009)
"To investigate the effectiveness of colchicine and dapsone, 2 corticosteroid-sparing anti-inflammatory agents, in the treatment of patients with complex aphthosis (recurrent oral and genital aphthous ulcers or severe, almost constant, multiple oral aphthae in the absence of Behçet syndrome)."	3.75	Successful treatment of complex aphthosis with colchicine and dapsone. ( Bruce, AJ; Lynde, CB; Rogers, RS, 2009)
"To detect the presence of rifampin- and dapsone-resistant strains of Mycobacterium leprae in three patients with recurring leprosy and clinically-suspected antimicrobial resistance through molecular techniques."	3.74	[Study of rifampin and dapsone resistance in three patients with recurring leprosy]. ( Beltrán, C; Cardona-Castro, N; Gómez, Y; Hernández, E; Kimura, M; Rodríguez, G; Villegas, S; Vissa, VD, 2008)
"Dapsone has been used successfully as adjuvant therapy for bullous pemphigoid (BP)."	3.73	Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases. ( Bröcker, EB; Goebeler, M; Kraensel, R; Rzany, B; Schmidt, E; Sinkgraven, R; Zillikens, D, 2005)
" The disease can be discriminated from prurigo simplex subacuta by the typical reticular hyperpigmentation, by the sparing of arms and legs and by the response to treatment with dapsone or minocycline."	3.71	[Prurigo pigmentosa]. ( Aramaki, J; Happle, R, 2001)
"Based upon the data from the Chinese National System for Leprosy Surveillance, this paper reports on the relapses in 297,343 leprosy patients [multibacillary (MB) 106,518, paucibacillary (PB) 190,825] cured by dapsone monotherapy."	3.70	Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy. ( Chen, XS; Jiang, C; Li, WZ; Ye, GY, 1999)
"There are many case reports of dapsone overdose in adults but only a few reports of dapsone-induced methemoglobinemia in children."	3.69	Acute dapsone intoxication: a pediatric case report. ( MacDonald, RD; McGuigan, MA, 1997)
"We report the first case of eosinophilic pustular folliculitis (Ofuji's disease) which was successfully treated with acitretin."	3.69	[Ofuji's eosinophilic pustular folliculitis. Efficacy of acitretin]. ( Bergoend, H; Catteau, B; Delaporte, E; Dubost-Brama, A; Piette, F; Warembourg, A, 1997)
"Many leprosy patients treated with multidrug therapy (MDT) had previously received dapsone (DDS) monotherapy for many years."	3.69	Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy. ( Britton, WJ; Neupane, K; Soares, DJ, 1995)
"The proportion of relapses among all patients detected each year increased steadily since the initiation of the national leprosy control program in China with dapsone monotherapy in 1955, reaching 18%-24% in the more leprosy-endemic provinces along the coast."	3.68	Problems of leprosy relapse in China. ( Li, HY, 1993)
"We analyzed the records of 1022 patients of paucibacillary leprosy who had received either 6 doses of WHO-MDT alone (" classical" MDT, 668 patients) or had post-MDT dapsone for at least 6 months ("modified" MDT, 354 patients)."	3.68	Fixed duration MDT in paucibacillary leprosy (classical and modified). ( Grugni, A; Kini, MS; Nadkarni, NJ, 1993)
"Before implementation of multidrug therapy (MDT), leprosy patients who were clinically inactive, skin-smear negative and had been treated with dapsone monotherapy for at least 5 years (paucibacillary patients) or for at least 10 years (multibacillary patients) were released from treatment."	3.68	Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. ( Becx-Bleumink, M, 1992)
"In an open study, a total of 18 patients with proven bullous pemphigoid (16 new patients and two in relapse) were treated with a trial of dapsone (17 patients) or sulphonimide (one patient)."	3.67	Dapsone as first line therapy for bullous pemphigoid. ( Millard, PR; Venning, VA; Wojnarowska, F, 1989)
"Three multidrug regimens all containing rifampin and dapsone have been tried for the treatment of 278 cases of paucibacillary leprosy."	3.67	Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin. ( Bagga, AK; Bhatia, AS; Katoch, K; Natrajan, M; Ramanathan, U; Ramu, G; Saxena, RK, 1989)
"Oral zinc sulfate was tried in Eight cases of recurrent Erythema Nodosum Leprosum."	3.66	Oral zinc in recurrent Erythema Nodosum Leprosum reaction. ( Bumb, RA; Mangal, HN; Mathur, NK, 1983)
"The 1,659 non-leprous people in a Micronesian population experiencing an annual leprosy incidence rate of about 7/1,000 were offered 15 acedapsone (DADDS) injections during 1967--1970 for leprosy prevention purposes."	3.66	Acedapsone in the prevention of leprosy: field trial in three high prevalence villages in Micronesia. ( Fasal, P; Jano, B; Russell, DA; Shepard, CC; Worth, RM, 1979)
"This is a report on two cases with pemphigus vulgaris effectively controlled by dapsone."	3.66	Dapsone in the treatment of pemphigus vulgaris. ( Friedman-Birnbaum, R; Haim, S, 1978)
" Reactive episodes continue to be a serious complication, but the availability of thalidomide to control erythema nodosum leprosum has markedly improved the prognosis."	3.65	The diagnosis and treatment of leprosy. ( Jacobson, RR; Trautman, JR, 1976)
"This paper summarises our clinical experience with clofazimine in the treatment of 25 cases of reactive states of lepromatous and borderline leprosy and 7 lepromatous patients not responding to dapsone."	3.65	Clinical trial with clofazimine in leprosy. ( Dongre, VV; Ganapati, R, 1976)
"Dapsone is an antibacterial sulfonamide with anti-inflammatory property, which showed therapeutic activity in patients with immune thrombocytopenia (ITP); the activity in patients who showed refractoriness to rituximab is unknown."	2.77	Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab. ( Chiozzotto, M; Fanin, R; Marin, L; Puglisi, S; Volpetti, S; Zaja, F, 2012)
"Colchicine was administered to a total of ten patients, with benefits observed in nine (90%), of whom four showed complete remission."	2.74	Systemic treatment in severe cases of recurrent aphthous stomatitis: an open trial. ( Hirota, SK; Migliari, DA; Mimura, MA; Sanches, JA; Sugaya, NN, 2009)
"No confirmed relapse has been observed within a follow-up period of 6 months to 7 years and 3 months [59 person-years at risk (PYR)] for TT/BT patients and of 4 months to 5 years and 10 months (100 PYR) for BB/BL/LL patients."	2.68	Daily multidrug therapy for leprosy; results of a fourteen-year experience. ( Cottenot, F; de Carsalade, GY; Flageul, B; Pennec, J; Spindler, E; Wallach, D, 1997)
"No further relapse has been diagnosed since the beginning of retreatment."	2.68	High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks. ( Grosset, JH; Jamet, P; Ji, B; Perani, EG; Sow, S; Traore, I, 1997)
"Rhinosporidiosis is a fairly common problem for the Otolaryngologist in many parts of the world, because of its prompt recurrence after surgical excision."	2.65	Clinical trial of diaminodiphenylsulfone (DDS) in nasal and nasopharyngeal rhinosporidiosis. ( Nair, KK, 1979)
"Pemphigus is a group of autoimmune intraepidermal bullous diseases; being pemphigus foliaceus (PF) and pemphigus vulgaris (PV) the most common subtypes."	2.53	Pemphigus foliaceus with circinated plaques and neutrophil pustules. ( Avalos-Diaz, E; Dominguez-Cherit, J; Esquivel-Pedraza, L; Méndez-Flores, S; Saeb-Lima, M, 2016)
" Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection."	2.50	Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014)
"Giant cell arteritis is a medium- and large-vessel vasculitis, the most prevalent systemic vasculitis in subjects over age 60."	2.44	[Giant cell arteritis]. ( Liozon, E; Ly, K, 2008)
"We describe a 46-year-old man with Hodgkin's disease in whom neutrophilic eccrine hidradenitis developed after each of the first two treatments with lomustine."	2.39	Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis. ( Knowles, SR; Poldre, P; Shapiro, L; Shear, NH, 1996)
"This is the first reported case of rhinosporidiosis in Ibadan, Nigeria."	2.39	Rhinosporodium: case report. ( Adeyemi, FA; Aghadiuno, PU; Akang, EE; Ashiru, JO; Ijaduola, GT, 1996)
"Relapses are an indicator of MDT effectiveness and can reflect Mycobacterium leprae persistence or re-infection."	1.62	Low rate of relapse after twelve-dose multidrug therapy for hansen's disease: A 20-year cohort study in a brazilian reference center. ( Hacker, MAVB; Illarramendi, X; Maia, RC; Moraes, MO; Nery, JAC; Sales, AM; Sarno, EN, 2021)
"Dapsone is a chemotherapeutic agent with anti-inflammatory properties that is used as a steroid-sparing agent in PV."	1.43	Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study. ( Barzilai, A; Baum, S; Debby, A; Gilboa, S; Trau, H, 2016)
"IgA pemphigus is a particular entity among autoimmune blistering intraepidermal diseases."	1.39	[Efficacy of acitretin in IgA pemphigus]. ( Bellissen, A; Gosset, P; Lasek, A; Lebas, D; Modiano, P; Wantz, M, 2013)
"Patients with Behcet's disease without oral ulcers and other diagnoses such as pemphigus vulgaris, lichen planus and herpes simplex were excluded."	1.38	Oral aphthosis: management gaps and recent advances. ( Liang, MW; Neoh, CY, 2012)
"Rhinosporidiosis is a non-contagious chronic granulomatous disease that is prevalent in southern India and Sri Lanka."	1.38	Rhinosporidiosis in southwest Bengal. ( Biswas, BK; Chowdhury, MK; Majhi, TK; Mallick, AA; Pal, DK, 2012)
"Rapid recurrence after stopping treatment however suggests that anti-inflammatory effects may predominate."	1.37	Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. ( Boer, J; Ingvarsson, G; Jemec, GB; Szepietowski, JC; Yazdanyar, S, 2011)
"Cutaneous periarteritis nodosa was diagnosed on histological findings and absence of extracutaneous manifestations."	1.33	[Reversible lower limb lymphedema as the first manifestation of cutaneous periarteritis nodosa]. ( Haicault de la Regontais, G; Hanslik, T; Stoyanova, M; Vasseur, E; Vignes, S, 2005)
"Eleven of these had a recrudescence of their infection."	1.33	Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response. ( Imwong, M; Krudsood, S; Looareesuwan, S; Nonprasert, A; Pukrittayakamee, S; Snounou, G; White, NJ; Wilairatana, P, 2005)
"Leprosy is well controlled in Hong Kong but continued surveillance is required to detect relapses and to ensure good patient compliance with treatment."	1.33	Epidemiology of leprosy and response to treatment in Hong Kong. ( Ho, CK; Lo, KK, 2006)
"Rhinosporidiosis is a chronic granulomatous disease that commonly affects the nasal and nasopharyngeal mucosa."	1.33	Disseminated rhinosporidiosis - an unusual presentation with pulmonary involvement. ( Jagdish, S; Pai, D; Rajakannu, M; Sri Vengadesh, G, 2006)
"We report two cases of Hansen's disease."	1.32	[Two cases of Hansen's disease]. ( Horii, N; Ichikawa, E; Ishii, N; Koseki, M; Otsuka, F; Sugita, Y; Tanaka, M, 2003)
"Areas of low endemicity of Hansen's disease, such as Texas, California, and Hawaii, exist due to immigration and rare autochthonous infections."	1.32	Short report: Treatment failure in Hansen's disease. ( Joyce, MP; Longfield, RN; Murray, CK, 2003)
"Skin biopsy supported diagnosis of polyarteritis nodosa."	1.31	[Cutaneous polyarteritis nodosa in children: three cases]. ( Assicot, C; Bourrat, E; Moraillon, I; Prigent, F; Rybojad, M; Triller, R; Vignon, MD, 2002)
"Treatment with dapsone may be beneficial."	1.30	Pterygium with granuloma faciale-like histologic picture. ( Havelius, U; Rausing, A, 1998)
"Cyclic neutropenia is a rare hematologic disorder of unknown origin."	1.30	[Recurrent episodes of ulcerative gingivostomatitis associated with cyclic neutropenia]. ( Djawari, J; Sucker, C, 1999)
" Therefore dapsone therapy was initiated at a dosage of 100 mg daily after checking the glucose-6-phosphate-dehydrogenase and with regular control of the blood methemoglobin level."	1.30	[Henoch-Schönlein purpura: successful treatment with Dapsone]. ( Abeck, D; Albrecht, J; Hein, R; Mempel, M; Ring, J, 1999)
"Recurrent erythema multiforme is an uncommon disorder."	1.29	Recurrent erythema multiforme: clinical features and treatment in a large series of patients. ( Leigh, IM; Schofield, JK; Tatnall, FM, 1993)
"One patient had a recurrence of PCP at 4 mo, after a negative 1-mo BAL."	1.29	Persistence of Pneumocystis carinii in patients with AIDS receiving chemoprophylaxis. ( Antonson, S; Epstein, LJ; Meyer, RD; Mohsenifar, Z; Strigle, SM, 1994)
"Occurrence or recurrence of PCP."	1.29	Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study. ( Hoover, DR; Kingsley, LA; Peng, Y; Phair, JP; Saah, AJ; Schrager, LK; Visscher, B, 1995)
"The prevention of the occurrence and recurrence of PCP is a cornerstone in the treatment of patients infected with the human immunodeficiency virus."	1.28	A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. ( Beall, GN; Beck, K; Cox, PH; Martin, MA; Styer, CM, 1992)
"Bullous pemphigoid is a clinically heterogeneous disease although little is known of the factors affecting its course and outcome."	1.28	Lack of predictive factors for the clinical course of bullous pemphigoid. ( Venning, VA; Wojnarowska, F, 1992)
"Dapsone was tried in one case with apparent benefit."	1.28	Eosinophilic pustulosis of the scalp in childhood. ( Bassan-Andrieu, L; Maleville, J; Taïeb, A, 1992)
"Ocular cicatricial pemphigoid (OCP) is a chronic, progressive, autoimmune disease that scars mucus membranes and may lead to blindness."	1.28	Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid. ( Foster, CS; Neumann, R; Tauber, J, 1991)
"In 33 consecutive AIDS patients with a first episode of Pneumocystis carinii pneumonia (PCP) we evaluated treatment, outcome, recurrence rate and pyrimethamine as chemoprophylaxis in a 1-year follow-up."	1.28	Pneumocystis carinii pneumonia in Stockholm, Sweden: treatment, outcome, one-year-follow-up and pyrimethamine prophylaxis. ( Bergdahl, S; Julander, I; Lidman, C; Lundbergh, P; Ortqvist, A, 1989)
"Dapsone has been used since 1976 in the treatment of relapsing polychondritis."	1.27	[Chronic atrophic polychondritis. Critical analysis of the therapeutic efficacy of dapsone. 2 cases]. ( Abadie, JC; Gouet, D; Marechaud, R; Neau, JP; Rossi, F; Sudre, Y, 1984)
" Nineteen patients had ocular manifestations of giant cell arteritis always from the onset, except for a fall in visual acuity; 26 relapses were observed in 18 patients, either during reduction of steroid dosage (21 cases) or after withdrawal (5 cases)."	1.27	[Prognosis of treated temporal arteritis. Retrospective study of 87 cases]. ( Alcalay, M; Becq-Giraudon, B; Boissonnot, L; Bontoux, D; Gil, R; Gouet, D; Le Berre, D; Lefevre, JP; Maréchaud, R; Risse, JF, 1986)
""Relapse" was defined as the reappearance of Mycobacterium leprae in skin smears."	1.27	Relapse rates in lepromatous leprosy according to treatment regularity. ( Almeida, JG; Chacko, CJ; Christian, M; Jesudasan, K, 1986)
"Dermatitis herpetiformis was diagnosed in seventy-six children by its clinical features and by detection of granular IgA deposits in the papillary dermis of perilesional skin."	1.27	Long-term follow-up of dermatitis herpetiformis in children. ( Cucchi, G; Ermacora, E; Gelmetti, C; Gianotti, F; Giunta, A; Pezzoli, G; Prampolini, L; Tettamanti, A; Tribbia, G, 1986)
" The initial dosage of either of the drugs was 300 mg daily administered in divided doses of 100 mg three times a day."	1.26	Treatment of steroid dependant cases of recurrent lepra reaction with a combination of thalidomide and clofazimine. ( Girdhar, A; Ramu, G, 1979)
" Low dosage favoured the appearance of resistance; therefore regular treatment of lepromatous leprosy with dapsone in full dosage is recommended."	1.25	Sulphone resistance in leprosy. A review of one hundred proven clinical cases. ( Pearson, JM; Rees, RJ; Waters, MF, 1975)

Research

Studies (187)

Authors

Clinical Trials (3)

Trial Overview

Trial Outcomes

B Cell Number at Week 24

Timeframe	Studies, this research(%)	All Research%
pre-1990	63 (33.69)	18.7374
1990's	52 (27.81)	18.2507
2000's	37 (19.79)	29.6817
2010's	31 (16.58)	24.3611
2020's	4 (2.14)	2.80

Authors	Studies
Andrade, ESN	1
Brandão, JG	1
Silva, JSD	1
Coriolano, CRF	1
Rosa, PS	3
Moraes, MO	2
Ferreira, CO	1
Gomes, CM	1
Araújo, WN	1
Wu, Z	1
Wang, C	1
Wang, Z	1
Shi, Y	1
Jiang, H	1
Wang, H	1
Davies, OMT	1
Hill, IM	1
Chiu, YE	1
Tagka, A	1
Lambrou, GI	1
Nicolaidou, E	1
Nakou, E	1
Makris, M	1
Stratigos, A	1
Katsarou, A	1
Nery, JAC	1
Sales, AM	1
Hacker, MAVB	1
Maia, RC	1
Sarno, EN	1
Illarramendi, X	1
Penna, GO	1
Bührer-Sékula, S	1
Kerr, LRS	1
Stefani, MMA	1
Rodrigues, LC	1
de Araújo, MG	1
Ramos, AMC	1
de Andrade, ARC	1
Costa, MB	1
Gonçalves, HS	1
Cruz, R	1
Barreto, ML	1
Pontes, MAA	1
Penna, MLF	1
Shah, PM	1
Dhakre, VW	1
Prasad, A	1
Samdani, P	1
Cambau, E	2
Saunderson, P	2
Matsuoka, M	1
Cole, ST	2
Kai, M	1
Suffys, P	1
Williams, D	1
Gupta, UD	1
Lavania, M	1
Cardona-Castro, N	3
Miyamoto, Y	1
Hagge, D	1
Srikantam, A	1
Hongseng, W	1
Indropo, A	1
Vissa, V	1
Johnson, RC	1
Cauchoix, B	1
Pannikar, VK	1
Cooreman, EAWD	1
Pemmaraju, VRR	1
Gillini, L	1
Tavares Rodrigues, F	1
Pereira Cardozo, MR	1
da Costa Nery, JA	1
Drerup, C	1
Hake, L	1
Oji, V	1
Sunderkötter, C	1
Hiraga, A	1
Ozaki, D	1
Oikawa, M	1
Araki, N	1
Kuwabara, S	1
Yates, M	1
Loke, YK	1
Watts, RA	1
MacGregor, AJ	1
Bellissen, A	1
Lebas, D	1
Wantz, M	1
Gosset, P	1
Lasek, A	1
Modiano, P	1
Koketsu, H	1
Ricotti, C	1
Kerdel, FA	1
Mael-Ainin, M	1
Senouci, K	1
Rotondo, C	1
Lopalco, G	1
Iannone, F	1
Vitale, A	1
Talarico, R	1
Galeazzi, M	1
Lapadula, G	1
Cantarini, L	1
Kitamura, S	1
Hamauchi, A	1
Ota, M	1
Watts, PJ	1
Khachemoune, A	1
Méndez-Flores, S	1
Avalos-Diaz, E	1
Dominguez-Cherit, J	1
Saeb-Lima, M	1
Esquivel-Pedraza, L	1
Baum, S	1
Debby, A	1
Gilboa, S	1
Trau, H	1
Barzilai, A	1
Beltrán-Alzate, C	1
López Díaz, F	1
Romero-Montoya, M	1
Sakamuri, R	1
Li, W	1
Kimura, M	2
Brennan, P	1
Oak, AS	1
Seminario-Vidal, L	1
Sami, N	1
Liozon, E	2
Ly, K	1
Chakma, JK	1
Girdhar, A	3
Natrajan, M	3
Kumar, A	1
Girdhar, BK	2
Owen, CE	1
Malone, JC	1
Callen, JP	1
Lynde, CB	1
Bruce, AJ	1
Rogers, RS	1
Mimura, MA	1
Hirota, SK	1
Sugaya, NN	1
Sanches, JA	1
Migliari, DA	1
Gallien, S	1
Bigé, N	1
Kitzis, MD	1
Longuet, P	1
Gervais, A	1
Leport, C	1
Jing, Z	1
Zhang, R	1
Zhou, D	1
Chen, J	1
Veien, NK	1
Moulis, G	1
Bagheri, H	1
Saint Martory, J	1
Bernard, P	2
Montastruc, JL	1
Maksimovic, L	1
Duriez, P	1
Lascaux-Cametz, AS	1
Andre, C	1
Bagot, M	1
Revuz, J	1
Ortonne, N	1
Balagon, MF	1
Cellona, RV	1
Abalos, RM	1
Gelber, RH	1
Saunderson, PR	1
Lekhanont, K	1
Patarakittam, T	1
Mantachote, K	1
Waiyawatjamai, P	1
Vongthongsri, A	1
Charneux, J	1
Maghanoy, A	1
Mallari, I	1
Balagon, M	1
Yazdanyar, S	1
Boer, J	1
Ingvarsson, G	1
Szepietowski, JC	1
Jemec, GB	1
Zaja, F	1
Marin, L	1
Chiozzotto, M	1
Puglisi, S	1
Volpetti, S	1
Fanin, R	1
Mori, S	1
Yotsu, RR	1
Suzuki, K	1
Makino, M	1
Ishii, N	2
Pal, DK	1
Mallick, AA	1
Majhi, TK	1
Biswas, BK	1
Chowdhury, MK	1
Durant, C	1
Hadj-Khelifa, S	1
Lei, J	1
Badaoui, A	1
Moreau, AS	1
Traineau, R	1
Farge, D	1
Decaux, O	1
Liang, MW	1
Neoh, CY	1
Sulo, J	1
Chimpeni, P	1
Hatcher, J	1
Kublin, JG	1
Plowe, CV	1
Molyneux, ME	1
Marsh, K	1
Taylor, TE	1
Watkins, WM	1
Winstanley, PA	1
Aviña-Zubieta, JA	1
Galindo-Rodrìguez, G	1
Robledo, I	1
Vela-Ojeda, J	1
Vadillo-Buenfil, M	1
Rosas-Cabral, A	1
Salazar-Exaire, D	1
Murray, CK	1
Joyce, MP	1
Longfield, RN	1
Ichikawa, E	1
Otsuka, F	1
Horii, N	1
Tanaka, M	1
Sugita, Y	1
Koseki, M	1
Bardella, MT	1
Fredella, C	1
Trovato, C	1
Ermacora, E	2
Cavalli, R	1
Saladino, V	1
Prampolini, L	2
Norman, G	1
Joseph, G	1
Richard, J	1
Lu, CI	1
Yang, CH	1
Hong, HS	1
Abramovits, W	1
Stevenson, LC	1
Krudsood, S	1
Imwong, M	1
Wilairatana, P	1
Pukrittayakamee, S	1
Nonprasert, A	1
Snounou, G	1
White, NJ	1
Looareesuwan, S	1
Vignes, S	1
Stoyanova, M	1
Vasseur, E	1
Haicault de la Regontais, G	1
Hanslik, T	1
Armour, KS	1
Scolyer, RA	1
Barnetson, RS	1
Shen, JP	1
Gupte, MD	1
Jiang, C	2
Manickam, P	1
Yu, MW	1
Li, WZ	2
Schmidt, E	1
Kraensel, R	1
Goebeler, M	1
Sinkgraven, R	1
Bröcker, EB	1
Rzany, B	1
Zillikens, D	2
Rose, C	1
Carthagena, L	1
Chauffour, A	1
Ji, B	2
Jarlier, V	1
Rajakannu, M	1
Sri Vengadesh, G	1
Pai, D	1
Jagdish, S	1
Hoffman, LD	1
Hoffman, MD	1
Ho, CK	1
Lo, KK	1
Fukae, J	1
Noda, K	1
Fujishima, K	1
Wada, R	1
Yoshiike, T	1
Hattori, N	1
Okuma, Y	1
Hernández, E	1
Rodríguez, G	1
Villegas, S	1
Beltrán, C	1
Vissa, VD	1
Gómez, Y	1
Sharquie, KE	1
Najim, RA	1
Al-Hayani, RK	1
Al-Nuaimy, AA	1
Maroof, DM	1
Sinha, MR	1
Gouet, D	2
Marechaud, R	2
Neau, JP	1
Abadie, JC	1
Rossi, F	1
Sudre, Y	1
Levy, L	3
Ji, BH	2
Chen, JK	1
Zhang, JL	1
Hou, YH	1
Ni, GX	1
Zhang, RB	1
Jesudasan, K	4
Christian, M	4
Bradley, D	1
Convit, J	1
Goihman-Yahr, M	1
Rondón-Lugo, AJ	1
Pattyn, SR	6
Eyckmans, L	1
Gigase, P	1
Mathur, NK	1
Bumb, RA	1
Mangal, HN	1
Yamasaki, R	1
Dekio, S	1
Moriyasu, S	1
Takagaki, K	1
Plechistova, LA	1
Salikhov, AS	1
Soares, DJ	1
Neupane, K	1
Britton, WJ	1
Smith, TC	1
Richardus, JH	1
Maier, H	1
Diem, E	1
Gotschim, A	1
Ortel, B	1
Katoch, K	2
Yadav, VS	1
Bhatia, AS	2
Hoernle, EH	1
Reid, TE	1
Lee, MW	1
Nixon, RL	1
Saah, AJ	1
Hoover, DR	1
Peng, Y	1
Phair, JP	1
Visscher, B	1
Kingsley, LA	1
Schrager, LK	1
Hernández, F	1
Linares, M	1
Colomina, P	1
Pastor, E	1
Cerveró, A	1
Pérez, A	1
Perella, M	1
Epstein, LJ	1
Meyer, RD	1
Antonson, S	1
Strigle, SM	1
Mohsenifar, Z	1
Jamet, P	3
Blanc, L	1
Fayne, OC	1
Traore, I	2
Bobin, P	1
Cartel, JL	3
Naudin, JC	1
Liozon, F	1
Vidal, E	1
Boutros-Toni, F	1
Gaches, F	1
Loustaud-Ratti, V	1
Berdah, JF	1
Honoré, N	1
Perrani, E	1
Telenti, A	1
Grosset, J	1
Ghys, P	1
Janssens, L	2
Tshilumba, K	1
Kuykens, L	3
Karibushi, N	1
Denis, P	1
Schadendorf, D	1
Haas, N	1
Nürnberger, F	1
Czarnetzki, BM	1
Li, HY	1
Nadkarni, NJ	1
Grugni, A	1
Kini, MS	1
Chauhan, SL	1
Malaviya, GN	1
Husain, S	1
Mukherjee, A	1
Schofield, JK	1
Tatnall, FM	1
Leigh, IM	1
Richards, FO	1
Kovacs, JA	2
Luft, BJ	1
Ashiru, JO	1
Ijaduola, GT	1
Aghadiuno, PU	1
Adeyemi, FA	1
Akang, EE	1
Shear, NH	1
Knowles, SR	1
Shapiro, L	1
Poldre, P	1
Cribier, B	1
Cuny, JF	1
Schubert, B	1
Colson, A	1
Truchetet, F	1
Grosshans, E	1
Ena, P	1
Lissia, M	1
Doneddu, GM	1
Campus, GV	1
MacDonald, RD	1
McGuigan, MA	1
de Carsalade, GY	1
Wallach, D	2
Spindler, E	1
Pennec, J	2
Cottenot, F	2
Flageul, B	2
Sow, S	1
Perani, EG	1
Grosset, JH	3
Marbiah, NT	1
Petersen, E	1
David, K	1
Magbity, E	1
Lines, J	1
Bradley, DJ	1
Sehgal, VN	1
Kumar, S	1
Jain, S	1
Bhattacharya, SN	1
Dubost-Brama, A	1
Delaporte, E	1
Catteau, B	1
Warembourg, A	1
Piette, F	1
Bergoend, H	1
Rausing, A	1
Havelius, U	1
Sucker, C	1
Djawari, J	1
Albrecht, J	1
Mempel, M	1
Hein, R	1
Abeck, D	1
Ring, J	1
Chen, XS	1
Ye, GY	1
Mahendran, R	1
Grant, JW	1
Norris, PG	1
Galaria, NA	1
Junkins-Hopkins, JM	1
Kligman, D	1
James, WD	1
Shaw, IN	2
Ebenezer, G	1
Rao, GS	2
Natrajan, MM	2
Balasundaram, B	1
Aramaki, J	1
Happle, R	1
Kaklamani, VG	1
Kaklamanis, PG	1
Kavitha, M	1

Trial	Phase	Enrollment	Study Type	Start Date	Status
Independent Study to Establish the Efficacy of the Six Doses Uniform MDT Regimen (U-MDT) for Leprosy Patients[NCT00669643]	Phase 4	859 participants (Actual)	Interventional	2007-02-28	Completed
Prospective Multicenter Randomized Open-label Controlled Trial Assessing Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia[NCT02627417]	Phase 3	216 participants (Anticipated)	Interventional	2015-12-31	Recruiting
Rituximab in the Treatment of Patients With Bullous Pemphigoid[NCT00286325]	Phase 1/Phase 2	8 participants (Actual)	Interventional	2005-03-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Peripheral blood B cell number at week 24 compared to B cell number at week 0 (NCT00286325)
Timeframe: Week 0 and at 24 weeks

IgG Anti Bullous Pemphigoid (BP) 180 Measured in Units by ELISA at Week 24.

Intervention	B cells per microliter (Median)
Treated	3.99

IgG antibodies against BP 180 measured in units (by ELISA) for each participant at week 0 compared to value at week 24, (NCT00286325)
Timeframe: Week 0 and at 24 weeks

Number of Days to Cessation of New Blister

Intervention	Elisa Units (Median)
Treated	40.5

The first study visit in which patient reported and was confirmed to have no new blister or lesion formation . (NCT00286325)
Timeframe: 1 year

Systemic Corticosteroid Dose of 25% of Starting Dose or 10 mg/Day by Week 24

Intervention	Days (Median)
Treated	57

Subject systemic corticosteroid dosage at week 24 was 25% of starting dose or 10 mg/day of prednisone or less (NCT00286325)
Timeframe: 24 weeks

Primary Safety Endpoint

Intervention	participants (Number)
Treated	7

The primary safety endpoint is the occurrence of treatment emergent adverse events including infections, infusion reactions and disease progression. These were determined by clinical evaluation and laboratory questions. Disease progression is defined as development of new blisters despite therapy. These are reported as the number of participants with a study related SAE. (NCT00286325)
Timeframe: 1 year

Article	Year
Risk factors for dapsone resistance in leprosy patients: a systematic meta-analysis. Journal of global antimicrobial resistance, 2022, Volume: 30 Topics: Dapsone; Humans; Leprosy; Mycobacterium leprae; Recurrence; Risk Factors	2022
A 13-year-old girl with recurrent oral ulcers. Pediatric dermatology, 2019, Volume: 36, Issue:6 Topics: Adolescent; Autoimmune Diseases; Dapsone; Diagnosis, Differential; Female; Humans; Mouth Mucosa; Ora	2019
Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. Clinical rheumatology, 2014, Volume: 33, Issue:2 Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dap	2014
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives. Mediators of inflammation, 2015, Volume: 2015 Topics: Anti-Bacterial Agents; Azathioprine; Behcet Syndrome; Colchicine; Dapsone; Humans; Interferon-alpha;	2015
Subcorneal Pustular Dermatosis: A Review of 30 Years of Progress. American journal of clinical dermatology, 2016, Volume: 17, Issue:6 Topics: Connective Tissue Diseases; Dapsone; Diagnosis, Differential; Glucocorticoids; Hematologic Diseases;	2016
Pemphigus foliaceus with circinated plaques and neutrophil pustules. Journal of cutaneous pathology, 2016, Volume: 43, Issue:11 Topics: Dapsone; Female; Humans; Neutrophils; Pemphigus; Prednisolone; Recurrence; Young Adult	2016
[Giant cell arteritis]. La Revue du praticien, 2008, Mar-15, Volume: 58, Issue:5 Topics: Adrenal Cortex Hormones; Aged, 80 and over; Anti-Infective Agents; Biopsy; Blood Sedimentation; C-Re	2008
Progressive keratolysis with pseudopterygium associated with erythema elevatum diutinum. Ophthalmology, 2011, Volume: 118, Issue:5 Topics: Anti-Infective Agents; Corneal Ulcer; Dapsone; Female; Humans; Middle Aged; Pterygium; Recurrence; S	2011
[Bullous pemphigoid: a review]. Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:3 Topics: Aged; Azathioprine; Clobetasol; Combined Modality Therapy; Dapsone; Dose-Response Relationship, Drug	2011
Evolution of the modern chemotherapy of leprosy. Leprosy review, 1983, Volume: Spec No Topics: Animals; Clofazimine; Dapsone; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance, Micro	1983
Human immunodeficiency virus infection in children. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, May-01, Volume: 52, Issue:9 Topics: Adolescent; AIDS-Related Opportunistic Infections; Child; Child, Preschool; Dapsone; Didanosine; Dru	1995
[Clinical course of Horton disease. Apropos of 42 cured patients]. Annales de medecine interne, 1994, Volume: 145, Issue:4 Topics: Aged; Aged, 80 and over; Dapsone; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednison	1994
Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21 Suppl 1 Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Infective Agents; Cats; Dapsone; Drug Therapy,	1995
Rhinosporodium: case report. East African medical journal, 1996, Volume: 73, Issue:6 Topics: Adolescent; Anti-Infective Agents; Combined Modality Therapy; Dapsone; Female; Humans; Nasal Polyps;	1996
Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis. Journal of the American Academy of Dermatology, 1996, Volume: 35, Issue:5 Pt 2 Topics: Antineoplastic Agents; Dapsone; Hidradenitis; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged;	1996
Erosive pustular dermatosis of the scalp in skin grafts: report of three cases. Dermatology (Basel, Switzerland), 1997, Volume: 194, Issue:1 Topics: Administration, Cutaneous; Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Infective Agents;	1997
Dapsone-responsive persistent erythema multiforme. Dermatology (Basel, Switzerland), 2000, Volume: 200, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Erythema Multiforme; Fema	2000
Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational proced International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1992, Volume: 60, Issue:3 Topics: Clofazimine; Dapsone; Epidemiologic Methods; Ethiopia; Humans; Incidence; Leprostatic Agents; Lepros	1992
Pneumocystis carinii pneumonia: therapy and prophylaxis. The Journal of infectious diseases, 1988, Volume: 158, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dapsone; Drug Combinations; Drug Therapy,	1988
Prevention of Pneumocystis carinii pneumonia. The Medical letter on drugs and therapeutics, 1988, Oct-07, Volume: 30, Issue:776 Topics: Acquired Immunodeficiency Syndrome; Aerosols; Dapsone; Drug Combinations; Humans; Pentamidine; Pneum	1988
Panniculitis associated with severe alpha 1-antitrypsin deficiency. Treatment and review of the literature. Archives of dermatology, 1987, Volume: 123, Issue:12 Topics: Adipose Tissue; Adult; Aged; alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Biopsy; Blood Prot	1987

Article	Year
Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients. PLoS neglected tropical diseases, 2017, Volume: 11, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brazil; Child; Child, Preschool; Clofazimine; Dapsone; D	2017
Systemic treatment in severe cases of recurrent aphthous stomatitis: an open trial. Clinics (Sao Paulo, Brazil), 2009, Volume: 64, Issue:3 Topics: Adolescent; Adult; Aged; Child; Colchicine; Dapsone; Drug Administration Schedule; Female; Follow-Up	2009
The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy. Leprosy review, 2010, Volume: 81, Issue:1 Topics: Adult; Dapsone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; L	2010
Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab. American journal of hematology, 2012, Volume: 87, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Contraindications; Dan	2012
Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial. Lancet (London, England), 2002, Oct-12, Volume: 360, Issue:9340 Topics: Antimalarials; Cause of Death; Child, Preschool; Dapsone; Developing Countries; Drug Combinations; D	2002
Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 2004, Volume: 72, Issue:1 Topics: Acedapsone; Aged; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans	2004
The therapeutic and prophylactic role of oral zinc sulfate in management of recurrent aphthous stomatitis (ras) in comparison with dapsone. Saudi medical journal, 2008, Volume: 29, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Analysis of Variance; Anti-Infective Agents; Astringents; C	2008
Relapse rates among nonlepromatous patients released from control. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1984, Volume: 52, Issue:3 Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Dapsone; Female; Humans; Leprosy; Male; Recurren	1984
A randomized clinical trial of two single-dose treatments for paucibacillary leprosy. Leprosy review, 1994, Volume: 65, Issue:1 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clofazimine; Dapsone; Drug Administration Schedule	1994
Daily multidrug therapy for leprosy; results of a fourteen-year experience. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1997, Volume: 65, Issue:1 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clofazimine; Dapsone; Drug Resistance, Microbial;	1997
High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:9 Topics: Adult; Anti-Infective Agents; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Fema	1997
A controlled trial of lambda-cyhalothrin-impregnated bed nets and/or dapsone/pyrimethamine for malaria control in Sierra Leone. The American journal of tropical medicine and hygiene, 1998, Volume: 58, Issue:1 Topics: Anti-Infective Agents; Bedding and Linens; Child; Child, Preschool; Dapsone; Humans; Infant; Insecti	1998
Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 2000, Volume: 68, Issue:4 Topics: Adult; Clofazimine; Cohort Studies; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; H	2000
Evaluation of treatment of lepromatous leprosy patients in the Netherlands. Dermatologica, 1979, Volume: 158, Issue:1 Topics: Clinical Trials as Topic; Clofazimine; Dapsone; Drug Evaluation; Humans; Leprostatic Agents; Leprosy	1979
Clinical trial of diaminodiphenylsulfone (DDS) in nasal and nasopharyngeal rhinosporidiosis. The Laryngoscope, 1979, Volume: 89, Issue:2 Pt 1 Topics: Dapsone; Drug Evaluation; Humans; Nasopharyngeal Diseases; Nose Diseases; Recurrence; Rhinosporidios	1979
Rifampin therapy of lepromatous leprosy. The American journal of tropical medicine and hygiene, 1975, Volume: 24, Issue:3 Topics: Acetamides; Animals; Clinical Trials as Topic; Dapsone; Drug Administration Schedule; Erythema Nodos	1975
Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years. The American journal of tropical medicine and hygiene, 1975, Volume: 24, Issue:3 Topics: Acetamides; Adolescent; Adult; Aged; Bacterial Infections; Child; Child, Preschool; Clinical Trials	1975
A controlled therapeutic trial in paucibacillary leprosy comparing a single dose of rifampicin with a single dose of rifampicin followed by one year of daily dapsone. The Collaborative Study Group for the Treatment of Leprosy in Zaire. Leprosy review, 1991, Volume: 62, Issue:2 Topics: Dapsone; Democratic Republic of the Congo; Drug Administration Schedule; Drug Therapy, Combination;	1991
Evaluation of five treatment regimens, using either dapsone monotherapy or several doses of rifampicin in the treatment of paucibacillary leprosy. Leprosy review, 1990, Volume: 61, Issue:2 Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprosy; Mycobacterium lep	1990
Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1985, Volume: 53, Issue:2 Topics: Adolescent; Adult; Dapsone; Drug Combinations; Drug Resistance; Humans; Isoniazid; Leprosy; Recurren	1985
Pulmonary tuberculosis treated with isoprodian and rifampicin or pyrazinamide. Chemotherapy, 1987, Volume: 33, Issue:3 Topics: Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Thera	1987

Article	Year
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan. Antimicrobial agents and chemotherapy, 2022, 05-17, Volume: 66, Issue:5 Topics: Anti-Bacterial Agents; Brazil; Cross-Sectional Studies; Dapsone; Drug Resistance, Bacterial; Drug Th	2022
Omalizumab in the Treatment of Chronic Urticaria: The Effect of Drug Co-Administration and Co-Morbidities. Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2021, Volume: 20, Issue:1 Topics: Anti-Allergic Agents; Chronic Urticaria; Comorbidity; Cyclosporine; Dapsone; Drug Therapy, Combinati	2021
Low rate of relapse after twelve-dose multidrug therapy for hansen's disease: A 20-year cohort study in a brazilian reference center. PLoS neglected tropical diseases, 2021, Volume: 15, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brazil; Child; Child, Preschool; Clofazimine; Dapsone; D	2021
Multiple cranial nerve palsies secondary to a recurrence of Hansen's disease. BMJ case reports, 2018, Jan-12, Volume: 2018 Topics: Adult; Cranial Nerve Diseases; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans;	2018
Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:12 Topics: Anti-Bacterial Agents; Bacterial Proteins; Biopsy, Needle; Brazil; Colombia; Dapsone; DNA Gyrase; Dr	2018
Widespread Dermatophytosis in a Patient Treated for Leprosy Type II Reactional State after MDT/WHO-MB Release. The American journal of tropical medicine and hygiene, 2018, Volume: 99, Issue:4 Topics: Antifungal Agents; Brazil; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromato	2018
Recurrent acute hemorrhagic edema of infancy (AHEI) during puberty. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2018, Volume: 16, Issue:12 Topics: Acute Disease; Adolescent; Age of Onset; Dapsone; Ecchymosis; Edema; Female; Hemorrhage; Humans; Pub	2018
Recurrent Neurological Episodes for 10 Years Preceding Skin Lesions in Neuro-Sweet Disease. Internal medicine (Tokyo, Japan), 2019, Dec-01, Volume: 58, Issue:23 Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Anti-Infective Agents; Dapsone; Diagnosis, Dif	2019
[Efficacy of acitretin in IgA pemphigus]. Annales de dermatologie et de venereologie, 2013, Volume: 140, Issue:12 Topics: Acitretin; Aged, 80 and over; Betamethasone; C-Reactive Protein; Dapsone; Female; Humans; Immunoglob	2013
Treatment of giant cellulitis-like Sweet syndrome with dapsone. JAMA dermatology, 2014, Volume: 150, Issue:4 Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Dapsone; Female; Humans; Middle Aged; Prednis	2014
[Verneuil's disease: a real therapeutic challenge]. The Pan African medical journal, 2014, Volume: 17 Topics: Acne Keloid; Adult; Chronic Disease; Dapsone; Folliculitis; Humans; Male; Recurrence	2014
Neuro-Sweet's disease. International journal of dermatology, 2016, Volume: 55, Issue:9 Topics: Adult; Anti-Inflammatory Agents; Brain Diseases; Dapsone; Drug Therapy, Combination; Humans; Male; M	2016
Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study. Dermatology (Basel, Switzerland), 2016, Volume: 232, Issue:5 Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Dapsone; Drug Therapy, Combination; Fe	2016
Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country. PLoS neglected tropical diseases, 2016, Volume: 10, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; Child; Colombia; Dapsone; DNA, Bacte	2016
Treatment of antiviral-resistant recurrent erythema multiforme with dapsone. Dermatologic therapy, 2017, Volume: 30, Issue:2 Topics: Adolescent; Adult; Anti-Infective Agents; Antiviral Agents; Dapsone; Drug Resistance; Erythema Multi	2017
Two microbiological relapses in a patient with lepromatous leprosy. Leprosy review, 2008, Volume: 79, Issue:3 Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprostatic Agents; Lepros	2008
Sweet-like dermatosis in 2 patients with clinical features of dermatomyositis and underlying autoimmune disease. Archives of dermatology, 2008, Volume: 144, Issue:11 Topics: Aged; Autoimmune Diseases; Biopsy, Needle; Dapsone; Dermatomyositis; Female; Follow-Up Studies; Gran	2008
Successful treatment of complex aphthosis with colchicine and dapsone. Archives of dermatology, 2009, Volume: 145, Issue:3 Topics: Adult; Anti-Inflammatory Agents; Colchicine; Dapsone; Drug Administration Schedule; Drug Therapy, Co	2009
Drug-to-drug interaction between dapsone and minocycline: an unusual cause of relapse of toxoplasmic encephalitis in an HIV-infected patient. Scandinavian journal of infectious diseases, 2009, Volume: 41, Issue:9 Topics: Adult; Dapsone; Drug Interactions; Encephalitis; HIV Infections; HIV-1; Humans; Male; Minocycline; R	2009
Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy. Leprosy review, 2009, Volume: 80, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Dapsone; Drug Therapy, Combination; Female; Follow-U	2009
Bullous pemphigoid masquerading as recurrent vesicular hand eczema. Acta dermato-venereologica, 2010, Volume: 90, Issue:1 Topics: Adrenal Cortex Hormones; Autoantibodies; Autoantigens; Basement Membrane; Collagen Type XVII; Comple	2010
Very late relapse of dapsone-induced methaemoglobinemia. European journal of clinical pharmacology, 2010, Volume: 66, Issue:6 Topics: Adult; Anti-Bacterial Agents; Dapsone; Dermatitis; Female; Humans; Immunosuppressive Agents; Lupus E	2010
[Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient]. Annales de dermatologie et de venereologie, 2010, Volume: 137, Issue:5 Topics: Dapsone; Dermis; Erythema; Foot Diseases; HIV Infections; Humans; Male; Middle Aged; Neutrophils; Py	2010
Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines. Leprosy review, 2011, Volume: 82, Issue:1 Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Lep	2011
Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. Dermatology (Basel, Switzerland), 2011, Volume: 222, Issue:4 Topics: Adult; Dapsone; Dermatologic Agents; Female; Glucosephosphate Dehydrogenase; Hidradenitis Suppurativ	2011
Present situation of leprosy in Japan, 2006-2010: analysis of drug resistance in new registered and relapsed cases by molecular biological methods. Journal of dermatological science, 2012, Volume: 67, Issue:3 Topics: Adult; Aged; Dapsone; Drug Resistance, Bacterial; Female; Humans; Japan; Leprostatic Agents; Leprosy	2012
Rhinosporidiosis in southwest Bengal. Tropical doctor, 2012, Volume: 42, Issue:3 Topics: Adolescent; Animals; Anti-Infective Agents; Child; Dapsone; Female; Humans; India; Male; Nasopharyng	2012
[Recurrent anemia in a 22-year-old woman]. La Revue de medecine interne, 2012, Volume: 33, Issue:9 Topics: Anemia, Hemolytic; Australia; Dapsone; Diagnosis, Differential; Female; Humans; Munchausen Syndrome;	2012
Oral aphthosis: management gaps and recent advances. Annals of the Academy of Medicine, Singapore, 2012, Volume: 41, Issue:10 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inf	2012
Long-term effectiveness of danazol corticosteroids and cytotoxic drugs in the treatment of hematologic manifestations of systemic lupus erythematosus. Lupus, 2003, Volume: 12, Issue:1 Topics: Adult; Anemia, Hemolytic; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathio	2003
Short report: Treatment failure in Hansen's disease. The American journal of tropical medicine and hygiene, 2003, Volume: 68, Issue:2 Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Lep	2003
[Two cases of Hansen's disease]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association, 2003, Volume: 72, Issue:3 Topics: Aged; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Male; Recurrence; Rif	2003
Long-term remission in patients with dermatitis herpetiformis on a normal diet. The British journal of dermatology, 2003, Volume: 149, Issue:5 Topics: Adolescent; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Co	2003
A bullous neutrophilic dermatosis in a patient with severe rheumatoid arthritis and monoclonal IgA gammopathy. Journal of the American Academy of Dermatology, 2004, Volume: 51, Issue:2 Suppl Topics: Adult; Arthritis, Rheumatoid; Biopsy; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Hu	2004
Sweet's syndrome associated with Staphylococcus aureus. International journal of dermatology, 2004, Volume: 43, Issue:12 Topics: Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Female; Follow-Up Studies; Humans; Middle Aged; Pr	2004
Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2005, Volume: 99, Issue:2 Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Dapsone; Dihydropteroate Syntha	2005
[Reversible lower limb lymphedema as the first manifestation of cutaneous periarteritis nodosa]. La Revue de medecine interne, 2005, Volume: 26, Issue:1 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Dapsone; Diagnosis, D	2005
Borderline lepromatous leprosy presenting as a single cutaneous plaque. The Australasian journal of dermatology, 2005, Volume: 46, Issue:3 Topics: Administration, Oral; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Forearm; Glucocorticoi	2005
Trends of case detection and other indicators of leprosy in China during 1985-2002. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2005, Volume: 20, Issue:2 Topics: Adolescent; Adult; Age Factors; Child; China; Communicable Disease Control; Dapsone; Disability Eval	2005
Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases. Cutis, 2005, Volume: 76, Issue:3 Topics: Administration, Oral; Administration, Topical; Aged; Anti-Inflammatory Agents; Clobetasol; Dapsone;	2005
[Hemorrhages in the fingers of a 45-year-old woman]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2003, Volume: 1, Issue:9 Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Celiac Disease; Dapsone; Derm	2003
Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jan-15, Volume: 42, Issue:2 Topics: Animals; Dapsone; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Resistance, Bacte	2006
Disseminated rhinosporidiosis - an unusual presentation with pulmonary involvement. International journal of dermatology, 2006, Volume: 45, Issue:3 Topics: Animals; Anti-Infective Agents; Dapsone; Follow-Up Studies; Foot Ulcer; Humans; Lung Diseases; Male;	2006
Dapsone in the treatment of persistent erythema multiforme. Journal of drugs in dermatology : JDD, 2006, Volume: 5, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Erythema Multiforme; Female; Humans; Middle Aged;	2006
Epidemiology of leprosy and response to treatment in Hong Kong. Hong Kong medical journal = Xianggang yi xue za zhi, 2006, Volume: 12, Issue:3 Topics: Clofazimine; Dapsone; Drug Resistance, Bacterial; Drug Therapy, Combination; Hong Kong; Humans; Inci	2006
Successful treatment of relapsing neuro-Sweet's disease with corticosteroid and dapsone combination therapy. Clinical neurology and neurosurgery, 2007, Volume: 109, Issue:10 Topics: Administration, Oral; Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Biopsy; Brain; Dapsone	2007
[Study of rifampin and dapsone resistance in three patients with recurring leprosy]. Revista panamericana de salud publica = Pan American journal of public health, 2008, Volume: 23, Issue:2 Topics: Aged; Dapsone; DNA, Bacterial; Drug Resistance, Microbial; Humans; Leprostatic Agents; Leprosy; Male	2008
Fixed genital drug eruption due to dapsone. A case report. Leprosy in India, 1982, Volume: 54, Issue:1 Topics: Adult; Dapsone; Drug Eruptions; Female; Genital Diseases, Female; Humans; Leprosy; Recurrence	1982
[Chronic atrophic polychondritis. Critical analysis of the therapeutic efficacy of dapsone. 2 cases]. Presse medicale (Paris, France : 1983), 1984, Mar-24, Volume: 13, Issue:12 Topics: Aged; Anemia, Hemolytic; Dapsone; Ear Cartilage; Ear Deformities, Acquired; Humans; Male; Middle Age	1984
Secondary dapsone-resistant leprosy in Shanghai Municipality. Leprosy review, 1983, Volume: 54, Issue:3 Topics: Animals; Dapsone; Drug Resistance, Microbial; Female; Humans; Leprosy; Male; Mice; Mycobacterium lep	1983
[Secondary dapsone resistance in leprotic patients of the Shanghai district]. Zhonghua yi xue za zhi, 1983, Volume: 63, Issue:4 Topics: Animals; China; Dapsone; Drug Resistance, Microbial; Female; Humans; Leprosy; Male; Mice; Recurrence	1983
Effectiveness of dapsone in Behcet's disease. The British journal of dermatology, 1984, Volume: 111, Issue:5 Topics: Behcet Syndrome; Dapsone; Humans; Recurrence; Stomatitis, Aphthous	1984
Late reversal reaction after combined treatment of a patient with multibacillary leprosy. Annales de la Societe belge de medecine tropicale, 1984, Volume: 64, Issue:3 Topics: Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Prothion	1984
Oral zinc in recurrent Erythema Nodosum Leprosum reaction. Leprosy in India, 1983, Volume: 55, Issue:3 Topics: Administration, Oral; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Fema	1983
Three cases of prurigo pigmentosa. The Journal of dermatology, 1981, Volume: 8, Issue:2 Topics: Dapsone; Humans; Male; Middle Aged; Pigmentation Disorders; Prurigo; Recurrence; Sulfamethoxazole	1981
[Long-term use of DDS by patients with Duhring's herpetiform dermatitis]. Vestnik dermatologii i venerologii, 1981, Issue:9 Topics: Dapsone; Dermatitis Herpetiformis; Humans; Male; Middle Aged; Recurrence; Time Factors	1981
Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy. Leprosy review, 1995, Volume: 66, Issue:3 Topics: Adult; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Leprostatic A	1995
Relapse rates in patients treated with dapsone monotherapy and combinations of dapsone and thiambutosine, thiacetazone, isoniazid and streptomycin in the pre-MDT era. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1994, Volume: 62, Issue:3 Topics: Dapsone; Drug Therapy, Combination; Female; Humans; Isoniazid; Leprostatic Agents; Leprosy; Male; Ph	1994
[Pyoderma gangrenosum as a precursor of myeloid leukemia]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1995, Volume: 46, Issue:9 Topics: Adult; Combined Modality Therapy; Cyclosporine; Dapsone; Female; Follow-Up Studies; Humans; Leukemia	1995
Response of leprosy patients with single lesions to MDT. Acta leprologica, 1995, Volume: 9, Issue:3 Topics: Adolescent; Adult; Arm; Dapsone; Drug Therapy, Combination; Facial Dermatoses; Follow-Up Studies; Hu	1995
Eosinophilic cellulitis case report: treatment options. The Australasian journal of dermatology, 1994, Volume: 35, Issue:2 Topics: Administration, Oral; Cellulitis; Cetirizine; Cyproheptadine; Dapsone; Drug Therapy, Combination; Eo	1994
Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study. JAMA, 1995, Apr-19, Volume: 273, Issue:15 Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Dapsone; HIV Infections; HIV-1;	1995
Dapsone for refractory chronic idiopathic thrombocytopenic purpura. British journal of haematology, 1995, Volume: 90, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Dapsone; Female; Humans; Middle Aged; P	1995
Persistence of Pneumocystis carinii in patients with AIDS receiving chemoprophylaxis. American journal of respiratory and critical care medicine, 1994, Volume: 150, Issue:5 Pt 1 Topics: Adult; AIDS-Related Opportunistic Infections; Bronchoalveolar Lavage Fluid; Dapsone; Humans; Male; M	1994
Relapses after a single dose of rifampin in skin-smear negative multibacillary patients after dapsone monotherapy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1994, Volume: 62, Issue:2 Topics: Adult; Aged; Confidence Intervals; Dapsone; Drug Administration Schedule; Drug Therapy, Combination;	1994
Rate of relapse in multibacillary patients after cessation of long-course dapsone monotherapy supplemented by a final supervised single dose of 1500 mg of rifampin. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1994, Volume: 62, Issue:2 Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans;	1994
A simple and rapid technique for the detection of rifampin resistance in Mycobacterium leprae. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1993, Volume: 61, Issue:4 Topics: Alleles; Amino Acid Sequence; Base Sequence; Dapsone; DNA Primers; DNA-Directed RNA Polymerases; DNA	1993
[Recurrent nodular panniculitis in alpha 1-antitrypsin deficiency. Successful dapsone therapy]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1993, Volume: 44, Issue:10 Topics: alpha 1-Antitrypsin Deficiency; Complement C3; Dapsone; Diagnosis, Differential; Female; Fluorescent	1993
Problems of leprosy relapse in China. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1993, Volume: 61, Issue:1 Topics: China; Clofazimine; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprosy; Recurren	1993
Fixed duration MDT in paucibacillary leprosy (classical and modified). International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1993, Volume: 61, Issue:1 Topics: Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Recurren	1993
Borderline-tuberculoid relapse in lepromatous leprosy. Leprosy review, 1993, Volume: 64, Issue:2 Topics: Dapsone; Female; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Male; Midd	1993
Recurrent erythema multiforme: clinical features and treatment in a large series of patients. The British journal of dermatology, 1993, Volume: 128, Issue:5 Topics: Acyclovir; Administration, Oral; Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Chr	1993
Recurrent annular erythema with purpura: a new variant of leucocytoclastic vasculitis responsive to dapsone. The British journal of dermatology, 1996, Volume: 135, Issue:6 Topics: Dapsone; Female; Humans; Male; Middle Aged; Recurrence; Skin; Vasculitis, Leukocytoclastic, Cutaneou	1996
Acute dapsone intoxication: a pediatric case report. Pediatric emergency care, 1997, Volume: 13, Issue:2 Topics: Antimalarials; Charcoal; Child, Preschool; Dapsone; Humans; Male; Methemoglobinemia; Methylene Blue;	1997
Relapse (reactivation) in borderline tuberculoid (BT) leprosy. The Journal of dermatology, 1998, Volume: 25, Issue:1 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Monitoring; Granuloma; Histiocyte	1998
[Ofuji's eosinophilic pustular folliculitis. Efficacy of acitretin]. Annales de dermatologie et de venereologie, 1997, Volume: 124, Issue:8 Topics: Acitretin; Dapsone; Eosinophils; Facial Dermatoses; Female; Folliculitis; Humans; Isotretinoin; Kera	1997
Pterygium with granuloma faciale-like histologic picture. Cornea, 1998, Volume: 17, Issue:5 Topics: Aged; Conjunctival Diseases; Dapsone; Female; Granuloma; Humans; Pterygium; Recurrence	1998
[Recurrent episodes of ulcerative gingivostomatitis associated with cyclic neutropenia]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1999, Volume: 50, Issue:7 Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Dapsone; Gingivitis, Necrotizing Ulcerative; Humans; M	1999
[Henoch-Schönlein purpura: successful treatment with Dapsone]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1999, Volume: 50, Issue:11 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Follow-Up Studies; Humans; IgA Vasculitis;	1999
Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1999, Volume: 67, Issue:4 Topics: China; Dapsone; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; National Health Programs; Po	1999
Neutrophilic dermatosis of the dorsal hands: pustular vasculitis revisited. Journal of the American Academy of Dermatology, 2000, Volume: 43, Issue:5 Pt 1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blister; Dapsone; Diagnosis, Differential; Female; Hand; Hu	2000
Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 2000, Volume: 68, Issue:3 Topics: Acedapsone; Adolescent; Adult; Animals; Child; Clofazimine; Dapsone; Drug Resistance, Microbial; Dru	2000
[Prurigo pigmentosa]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2001, Volume: 52, Issue:2 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Stero	2001
Treatment of Behçet's disease--an update. Seminars in arthritis and rheumatism, 2001, Volume: 30, Issue:5 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chl	2001
Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy. Archives of dermatology, 2001, Volume: 137, Issue:9 Topics: Adult; Aged; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunization, Pa	2001
Neutrophilic dermatosis (pustular vasculitis) of the dorsal hands: a report of 7 cases and review of the literature. Archives of dermatology, 2002, Volume: 138, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Fe	2002
[Cutaneous polyarteritis nodosa in children: three cases]. Annales de dermatologie et de venereologie, 2002, Volume: 129, Issue:2 Topics: Adolescent; Adrenal Cortex Hormones; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; C	2002
Sulphone resistance in leprosy. A review of one hundred proven clinical cases. Lancet (London, England), 1975, Jul-12, Volume: 2, Issue:7924 Topics: Adolescent; Adult; Animals; Child; Dapsone; Drug Resistance, Microbial; Female; Humans; Leprosy; Mal	1975
Clinical assessment and management of dapsone-resistant leprosy for the field worker. Leprosy review, 1977, Volume: 48, Issue:2 Topics: Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Recurrence	1977
Antibody activity against Mycobacterium leprae antigen 7 in leprosy: studies on variation in antibody content throughout the spectrum and on the effect of DDS treatment and relapse in BT leprosy. Leprosy review, 1979, Volume: 50, Issue:2 Topics: Antibodies, Bacterial; Antigens, Bacterial; Dapsone; Humans; Leprosy; Mycobacterium leprae; Recurren	1979
Workshop on "chemotherapy of leprosy" at the Central Leprosy Teaching and Research Institute, Chengalpattu (Tamil Nadu) on 21 January 1978. Leprosy in India, 1979, Volume: 51, Issue:1 Topics: Clofazimine; Dapsone; Humans; India; Leprosy; Recurrence; Rifampin; Thalidomide	1979
Acedapsone in the prevention of leprosy: field trial in three high prevalence villages in Micronesia. The American journal of tropical medicine and hygiene, 1979, Volume: 28, Issue:3 Topics: Acedapsone; Adult; Child; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Micronesia; Patient	1979
[Chemotherapy of leprosy. I. Sulfones and sulfonamides]. Nederlands tijdschrift voor geneeskunde, 1979, Jun-09, Volume: 123, Issue:23 Topics: Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Erythema Nodosum; Humans; Leprostati	1979
Treatment of steroid dependant cases of recurrent lepra reaction with a combination of thalidomide and clofazimine. Leprosy in India, 1979, Volume: 51, Issue:4 Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Male; Recurrence; Steroids;	1979
Dapsone in the treatment of pemphigus vulgaris. Dermatologica, 1978, Volume: 156, Issue:2 Topics: Adult; Dapsone; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Pemp	1978
Srategy of leprosy control. WHO chronicle, 1978, Volume: 32, Issue:5 Topics: BCG Vaccine; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy; Population Surveillance	1978
Relaspe in leprosy. British medical journal, 1977, Oct-08, Volume: 2, Issue:6092 Topics: Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Recurrence	1977
The diagnosis and treatment of leprosy. Southern medical journal, 1976, Volume: 69, Issue:8 Topics: Biopsy; Clofazimine; Dapsone; Erythema Nodosum; Humans; Immunotherapy; Leprosy; Recurrence; Rifampin	1976
Inactivation and relapse in bacterio-negative cases of leprosy under sulphone therapy: a 4 1/2 years follow-up. Leprosy in India, 1976, Volume: 48, Issue:4 Suppl Topics: Dapsone; Female; Follow-Up Studies; Humans; Leprosy; Male; Recurrence	1976
Clinical trial with clofazimine in leprosy. Leprosy in India, 1976, Volume: 48, Issue:4 Suppl Topics: Adolescent; Adrenal Cortex Hormones; Adult; Child; Clofazimine; Dapsone; Drug Therapy, Combination;	1976
Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1992, Volume: 60, Issue:2 Topics: Adolescent; Adult; Child; Child, Preschool; Dapsone; Ethiopia; Eye Infections, Bacterial; Female; Hu	1992
A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Archives of internal medicine, 1992, Volume: 152, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Dapsone; Drug Administration Schedule; Drug Therapy	1992
Eight years of follow-up of paucibacillary patients treated with short-course regimens. Leprosy review, 1992, Volume: 63, Issue:1 Topics: Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprosy; Recurrence; Rifampin	1992
Lack of predictive factors for the clinical course of bullous pemphigoid. Journal of the American Academy of Dermatology, 1992, Volume: 26, Issue:4 Topics: Aged; Aged, 80 and over; Autoimmune Diseases; Azathioprine; Dapsone; Drug Therapy, Combination; Fema	1992
Eosinophilic pustulosis of the scalp in childhood. Journal of the American Academy of Dermatology, 1992, Volume: 27, Issue:1 Topics: Child, Preschool; Dapsone; Diagnosis, Differential; Eosinophilia; Female; Folliculitis; Humans; Infa	1992
[Gastrointestinal involvement and the response to dapsone in a case of the urticarial vasculitis syndrome]. Medicina clinica, 1991, Nov-23, Volume: 97, Issue:18 Topics: Adult; Chronic Disease; Dapsone; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Human	1991
Risk of relapse among non-lepromatous patients released from treatment after dapsone monotherapy. Leprosy review, 1991, Volume: 62, Issue:3 Topics: Adolescent; Adult; Child; Child, Preschool; Dapsone; Female; Humans; Infant; Leprosy; Male; Recurren	1991
Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid. Ophthalmology, 1991, Volume: 98, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Cyclophosphamide; Dapsone; Female; Follow-Up Studies;	1991
Longitudinal study on relapses of leprosy in Polynesian multibacillary patients on dapsone monotherapy between 1946 and 1970. Leprosy review, 1991, Volume: 62, Issue:2 Topics: Dapsone; Humans; Leprosy; Longitudinal Studies; Polynesia; Probability; Recurrence; Risk	1991
A retrospective study on seven years of multiple drug treatment for paucibacillary and multibacillary leprosy, in Bayara General Hospital, Nigeria. Leprosy review, 1991, Volume: 62, Issue:2 Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Administration Schedule; Drug Resistance, Microbial; D	1991
[Sulfones in alopecia areata]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1991, Volume: 42, Issue:5 Topics: Alopecia Areata; Dapsone; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Recurrence	1991
Superficial granulomatous pyoderma. International journal of dermatology, 1991, Volume: 30, Issue:6 Topics: Adult; Chronic Disease; Dapsone; Diagnosis, Differential; Granuloma; Humans; Male; Minocycline; Pyod	1991
A case of relapse with drug-susceptible M. leprae after multidrug therapy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1991, Volume: 59, Issue:2 Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Male;	1991
[Late reversal reactions in leprosy]. Acta leprologica, 1990, Volume: 7, Issue:2 Topics: Clofazimine; Dapsone; Drug Combinations; Ethionamide; Female; Humans; Leprosy; Male; Recurrence; Rif	1990
Relapses in multibacillary leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1990, Volume: 58, Issue:2 Topics: Dapsone; Humans; Leprosy; Recurrence	1990
Pneumocystis carinii pneumonia in Stockholm, Sweden: treatment, outcome, one-year-follow-up and pyrimethamine prophylaxis. Scandinavian journal of infectious diseases, 1989, Volume: 21, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Dapsone; Drug Evaluation; Drug Therapy, Combination	1989
Dapsone as first line therapy for bullous pemphigoid. The British journal of dermatology, 1989, Volume: 120, Issue:1 Topics: Aged; Aged, 80 and over; Dapsone; Female; Humans; Male; Middle Aged; Pemphigoid, Bullous; Recurrence	1989
Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1989, Volume: 57, Issue:2 Topics: Adult; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lepromin; L	1989
Rate and time distribution of relapses in multibacillary leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1989, Volume: 57, Issue:3 Topics: Dapsone; Humans; Leprosy; Recurrence; Retrospective Studies; Time Factors	1989
Changing picture of leprosy in North Arcot District, Tamil Nadu after M.D.T. Indian journal of leprosy, 1989, Volume: 61, Issue:1 Topics: Clofazimine; Cohort Studies; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; India; L	1989
[Prognosis of treated temporal arteritis. Retrospective study of 87 cases]. Presse medicale (Paris, France : 1983), 1986, Mar-29, Volume: 15, Issue:13 Topics: Aged; Chloroquine; Cyclophosphamide; Dapsone; Drug Therapy, Combination; Female; Giant Cell Arteriti	1986
[Action of nitroquine on tissue schizonts of Plasmodium cynomolgi]. Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1986, Volume: 7, Issue:1 Topics: Animals; Antimalarials; Dapsone; Female; Macaca mulatta; Malaria; Male; Plasmodium; Quinazolines; Re	1986
Treatment of Pneumocystis carinii pneumonia. The Medical letter on drugs and therapeutics, 1987, Nov-20, Volume: 29, Issue:753 Topics: Acquired Immunodeficiency Syndrome; Dapsone; Drug Combinations; Folic Acid Antagonists; Humans; Meth	1987
Relapse of paucibacillary leprosy after short course multidrug therapy. Indian journal of leprosy, 1988, Volume: 60, Issue:2 Topics: Adult; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leprosy, Tu	1988
Leprosy control based on multi drug treatment in India. Indian journal of leprosy, 1988, Volume: 60, Issue:2 Topics: Allied Health Personnel; Clofazimine; Dapsone; Data Collection; Drug Administration Schedule; Drug T	1988
Relapse or reversal reaction: the case for a therapeutic trial of steroids. Leprosy review, 1988, Volume: 59, Issue:3 Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Male; Prednisolone; Recurren	1988
Pattern of relapses in pauci-bacillary leprosy patients treated with M.D.T. (W.H.O. 1982). Indian journal of leprosy, 1988, Volume: 60, Issue:4 Topics: Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Recurrence; Rifampin; Sex Factors	1988
[Recurrent polychondritis (report of a case)]. Medicina cutanea ibero-latino-americana, 1987, Volume: 15, Issue:4 Topics: Atrophy; Basal Ganglia; Calcinosis; Cartilage Diseases; Conjunctiva; Dapsone; Ear, External; Female;	1987
Contribution of relapses to total infection sources of leprosy in Guadeloupe. Leprosy review, 1987, Volume: 58, Issue:4 Topics: Adult; Child; Dapsone; Female; Humans; Leprosy; Male; Recurrence; West Indies	1987
Relapse rates in lepromatous leprosy according to treatment regularity. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1986, Volume: 54, Issue:1 Topics: Dapsone; Humans; Leprosy; Mycobacterium leprae; Recurrence; Skin; Time Factors	1986
Combined chemotherapy of multibacillary leprosy of 6 months' duration. Leprosy review, 1986, Volume: 57 Suppl 3 Topics: Adolescent; Adult; Child; Child, Preschool; Clofazimine; Dapsone; Drug Therapy, Combination; Female;	1986
Preliminary results of treatment of leprosy patients in The Netherlands with daily rifampicin, dapsone and clofazimine. Leprosy review, 1986, Volume: 57 Suppl 3 Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Netherlands; Recurrence; Rifampin	1986
First assessment of the Malta Leprosy Eradication Project. Leprosy review, 1986, Volume: 57 Suppl 3 Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Evaluation Studies as Topic; Follow-Up Studie	1986
Long-term follow-up of dermatitis herpetiformis in children. Journal of the American Academy of Dermatology, 1986, Volume: 15, Issue:1 Topics: Child; Child, Preschool; Combined Modality Therapy; Dapsone; Dermatitis Herpetiformis; Female; Follo	1986
The rate of relapse in lepromatous leprosy following completion of twenty years of supervised sulphone therapy. Leprosy review, 1986, Volume: 57, Issue:2 Topics: Dapsone; Female; Humans; Leprosy; Male; Recurrence; Sulfones	1986
The Kellersberger memorial lecture, 1984. Chemotherapy of leprosy--a tool for leprosy control. Ethiopian medical journal, 1985, Volume: 23, Issue:1 Topics: Dapsone; Drug Therapy, Combination; Ethiopia; Humans; Leprostatic Agents; Leprosy; Recurrence	1985
Risk of paucibacillary leprosy patients released from control relapsing with multibacillary leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1985, Volume: 53, Issue:1 Topics: Dapsone; Humans; Lepromin; Leprosy; Recurrence; Risk	1985
[Palindromic rheumatism: efficacy of dapsone]. Revue du rhumatisme et des maladies osteo-articulaires, 1985, Volume: 52, Issue:10 Topics: Arthritis; Dapsone; Humans; Male; Middle Aged; Recurrence	1985
Acantholytic herpetiform dermatitis. Archives of dermatology, 1973, Volume: 107, Issue:6 Topics: Acantholysis; Antibodies; Antibodies, Antinuclear; Biopsy; Blister; Dapsone; Dermatitis Herpetiformi	1973
Quinine infusion for recrudescences of falciparum malaria in Vietnam: a controlled study. The American journal of tropical medicine and hygiene, 1972, Volume: 21, Issue:6 Topics: Dapsone; Humans; Infusions, Parenteral; Malaria; Plasmodium falciparum; Pyrimethamine; Quinine; Recu	1972
Recrudescent falciparum malaria in Vietnam. The American journal of tropical medicine and hygiene, 1973, Volume: 22, Issue:3 Topics: Adult; Black People; Dapsone; Fever; Follow-Up Studies; Humans; Malaria; Male; Military Medicine; Pl	1973
Chemoprophylaxis of malaria for travelers. Annals of internal medicine, 1974, Volume: 81, Issue:2 Topics: Africa; Antimalarials; Asia; Central America; Chloroquine; Dapsone; Drug Resistance, Microbial; Drug	1974
Hormonal factors in dermatitis herpetiformis. Report of two cases. Dermatologica, 1972, Volume: 145, Issue:3 Topics: Adolescent; Adult; Contraceptives, Oral; Dapsone; Dermatitis Herpetiformis; Estrogens; Female; Human	1972
Mycetoma pedis, a report of two cases. Israel journal of medical sciences, 1973, Volume: 9, Issue:7 Topics: Chloramphenicol; Dapsone; Ethambutol; Foot Dermatoses; Humans; Male; Middle Aged; Mycetoma; Radiogra	1973
Metabolic disposition of dapsone in patients with dapsone-resistant leprosy. The American journal of tropical medicine and hygiene, 1974, Volume: 23, Issue:2 Topics: Acylation; Adult; Aged; Dapsone; Drug Resistance, Microbial; Female; Humans; Leprosy; Male; Middle A	1974

dapsone and Recrudescence